igf 1 lr3 minimize side effects harm reduction New insights on the cardiovascular of IGF-1 Late-life targeting of the IGF-1
Description
Current pharmacological interventions primarily focus on three key dimensions: lactate metabolic enzymes, lactate transporters, and lactylation regulators
Watson M
Glutathione is naturally present in the body, but decreases with age
Nov 30 2018;71(11-12):411-416
On the other hand, the hyperactivation of the Notch signaling pathway has been observed in the prefrontal cortex, hippocampus, and cerebellum of ASD models
Banks C
